|
Articles |
Integrated by Design
|
| Strategic pathways for drug-led combination products |
| Venkat Reddy Sunkara,
Global Head of Regulatory CMC, ICON |
|
|
Broadly speaking, combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products... |
From Gene Editing to Network Medicine
|
| How CRISPR, Programmable Gene Circuits, and AI-Driven Intrinsic Network Pharmacology May Transform Next-Generation Drug Discovery |
| Dr. Prof. Dr. Hemanth Kumar Manikyam,
Vice President Research And Development, Botanic Healthcare
|
|
| Gene editing technologies such as CRISPR have transformed biomedical research, yet future therapeutics may emerge from integrating... |
|
|
| Stephanie Willerth, CEO, Axolotl Biosciences
|
|
